000 | 01917 a2200529 4500 | ||
---|---|---|---|
005 | 20250513171102.0 | ||
264 | 0 | _c19990421 | |
008 | 199904s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTolliver, B K | |
245 | 0 | 0 |
_aBehavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cApr 1999 |
||
300 |
_a110-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aBenztropine _xadministration & dosage |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 |
_aCocaine _xpharmacokinetics |
650 | 0 | 4 |
_aDiscrimination Learning _xdrug effects |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
650 | 0 | 4 |
_aDopamine Uptake Inhibitors _xpharmacokinetics |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Antagonism |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMembrane Glycoproteins |
650 | 0 | 4 | _aMembrane Transport Proteins |
650 | 0 | 4 | _aMicrodialysis |
650 | 0 | 4 | _aMicroinjections |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 | _aNerve Tissue Proteins |
650 | 0 | 4 |
_aNucleus Accumbens _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
700 | 1 | _aNewman, A H | |
700 | 1 | _aKatz, J L | |
700 | 1 | _aHo, L B | |
700 | 1 | _aFox, L M | |
700 | 1 | _aHsu, K | |
700 | 1 | _aBerger, S P | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 289 _gno. 1 _gp. 110-22 |
|
999 |
_c10046747 _d10046747 |